7
Participants
Start Date
May 16, 2023
Primary Completion Date
May 29, 2026
Study Completion Date
May 29, 2026
VX-264
Allogeneic human stem cell-derived islets.
University of Pittsburgh Medical Center Montefiore, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
UHealth Diabetes Research Institute, Miami
University of Wisconsin, Madison
University of Chicago, Chicago
Massachusetts General Hospital, Boston
University of Alberta, Edmonton, Edmonton
Montreal Clinical Research Institute, Montreal
Toronto General Hospital (TGH), Toronto
Vancouver General Hospital, Vancouver
Dresden Center for Islet Transplantation, Dresden
IRCCS Ospedale San Raffaele, Milan
Leiden University, Leiden
Hopiteaux Universitaires de Geneve, Geneva
Churchill Hospital, Headington
Royal Victoria Infirmary, Newcastle upon Tyne
Vertex Pharmaceuticals Incorporated
INDUSTRY